Dr. Christopher Sherman

Dr. Christopher Sherman
Dr. Sherman is a Board-Certified Urologist originally from Coral Springs, Florida and currently assigned at Advanced Urology Institute in Largo, FL. He received his undergraduate degree in Health Science from the University of Florida in 2006 and his medical school degree from Florida State University College of Medicine in 2010. After one year of training in general surgery, he completed a four year residency in Urology at the University of Louisville in Kentucky. Dr. Sherman then joined our practice in 2015. He is currently the chief of the urology department at Morton Plant hospital. Dr. Sherman has a strong interest in treating voiding dysfunction, including the following treatments: Sacroneuromodulation treatments for overactive or underactive bladder Bladder botox injection for overactive bladder Minimally invasive prostate procedures in the office such as Urolift He also specializes in advanced treatments for prostate cancer.

Languages Spoken:


Medical School:

Graduated from Florida State University College of Medicine in 2010


2010-2011 General Surgery at University of Louisville 2011-2015 Urology at University of Louisville


Graduated from University of Florida – 2006

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only